Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Argus Research Maintains Buy on MetLife, Raises Price Target to $80

Author: Benzinga Newsdesk | May 22, 2024 11:33am

Argus Research analyst Kevin Heal maintains MetLife (NYSE:MET) with a Buy and raises the price target from $77 to $80.

Posted In: MET